BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 18094416)

  • 21. Genome-wide oligonucleotide microarray analysis of gene-expression profiles of Taiwanese patients with anaplastic astrocytoma and glioblastoma multiforme.
    Chang CL
    J Biomol Screen; 2008 Oct; 13(9):912-21. PubMed ID: 18812569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robustness of gene expression profiling in glioma specimen samplings and derived cell lines.
    Mehrian Shai R; Reichardt JK; Ya-Hsuan H; Kremen TJ; Liau LM; Cloughesy TF; Mischel PS; Nelson SF
    Brain Res Mol Brain Res; 2005 May; 136(1-2):99-103. PubMed ID: 15893592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting clinical outcome through molecular profiling in stage III melanoma.
    John T; Black MA; Toro TT; Leader D; Gedye CA; Davis ID; Guilford PJ; Cebon JS
    Clin Cancer Res; 2008 Aug; 14(16):5173-80. PubMed ID: 18698035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Focused microarray analysis of glyco-gene expression in human glioblastomas.
    Kroes RA; Dawson G; Moskal JR
    J Neurochem; 2007 Nov; 103 Suppl 1():14-24. PubMed ID: 17986135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microarray analysis of MRI-defined tissue samples in glioblastoma reveals differences in regional expression of therapeutic targets.
    Van Meter T; Dumur C; Hafez N; Garrett C; Fillmore H; Broaddus WC
    Diagn Mol Pathol; 2006 Dec; 15(4):195-205. PubMed ID: 17122647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.
    Oberthuer A; Berthold F; Warnat P; Hero B; Kahlert Y; Spitz R; Ernestus K; König R; Haas S; Eils R; Schwab M; Brors B; Westermann F; Fischer M
    J Clin Oncol; 2006 Nov; 24(31):5070-8. PubMed ID: 17075126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and prognostic value of glycosyltransferase mRNA in glioblastoma multiforme patients.
    Oblinger JL; Pearl DK; Boardman CL; Saqr H; Prior TW; Scheithauer BW; Jenkins RB; Burger PC; Yates AJ
    Neuropathol Appl Neurobiol; 2006 Aug; 32(4):410-8. PubMed ID: 16866986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The diagnosis and prognosis of gliomas of the cerebral hemispheres after a study of 245 cases].
    Van Gehuchten P; Brucher JM; Cornelis G
    Acta Neurol Psychiatr Belg; 1967 Oct; 67(10):797-813. PubMed ID: 4295150
    [No Abstract]   [Full Text] [Related]  

  • 30. Differentiation of follicular thyroid adenoma from carcinoma by means of gene expression profiling with adapter-tagged competitive polymerase chain reaction.
    Taniguchi K; Takano T; Miyauchi A; Koizumi K; Ito Y; Takamura Y; Ishitobi M; Miyoshi Y; Taguchi T; Tamaki Y; Kato K; Noguchi S
    Oncology; 2005; 69(5):428-35. PubMed ID: 16319515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression profiling from formalin-fixed paraffin-embedded tumors of pediatric glioblastoma.
    Haque T; Faury D; Albrecht S; Lopez-Aguilar E; Hauser P; Garami M; Hanzély Z; Bognár L; Del Maestro RF; Atkinson J; Nantel A; Jabado N
    Clin Cancer Res; 2007 Nov; 13(21):6284-92. PubMed ID: 17975139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preliminary study on the gene expression profiles of oligodendrogliom as with cDNA array].
    Jiang R; Pu P; Zheng Y; Kang C; Wang G; Wang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):379-82. PubMed ID: 12362310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors.
    Faury D; Nantel A; Dunn SE; Guiot MC; Haque T; Hauser P; Garami M; Bognár L; Hanzély Z; Liberski PP; Lopez-Aguilar E; Valera ET; Tone LG; Carret AS; Del Maestro RF; Gleave M; Montes JL; Pietsch T; Albrecht S; Jabado N
    J Clin Oncol; 2007 Apr; 25(10):1196-208. PubMed ID: 17401009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.
    Nobusawa S; Watanabe T; Kleihues P; Ohgaki H
    Clin Cancer Res; 2009 Oct; 15(19):6002-7. PubMed ID: 19755387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variables.
    Zhou YH; Hess KR; Liu L; Linskey ME; Yung WK
    Neuro Oncol; 2005 Oct; 7(4):485-94. PubMed ID: 16212813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional changes in U343 MG-a glioblastoma cell line exposed to ionizing radiation.
    Bassi C; Mello SS; Cardoso RS; Godoy PD; Fachin AL; Junta CM; Sandrin-Garcia P; Carlotti CG; Falcão RP; Donadi EA; Passos GA; Sakamoto-Hojo ET
    Hum Exp Toxicol; 2008 Dec; 27(12):919-29. PubMed ID: 19273547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
    van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteration of gene expression during nasopharyngeal carcinogenesis revealed by oligonucleotide microarray after microdissection of tumor tissue and normal epithelia from nasopharynx.
    Liu ZQ; Tian YQ; Hu YF; Li XL; Ma FR; Li GY
    Chin Med J (Engl); 2009 Feb; 122(4):437-43. PubMed ID: 19302751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
    Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
    Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
    Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
    Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.